흡연 중단 및 니코틴 탈중독 제품 시장 보고서(2026년)
Smoking Cessation And Nicotine De-Addiction Products Global Market Report 2026
상품코드 : 1957807
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

흡연 중단 및 니코틴 탈중독 제품 시장 규모는 최근 급성장하고 있습니다. 2025년 259억 1,000만 달러에서 2026년에는 287억 5,000만 달러에 이르고, CAGR 11.0%의 성장이 전망되고 있습니다. 지난 수년간의 성장에는 흡연과 관련된 건강 위험에 대한 인식 증가, 정부 주도의 금연 캠페인 확대, 일반의약품을 통한 금연 제품 보급, 처방약 치료의 성장, 의료 서비스 제공업체의 참여 증가 등이 주요 요인으로 작용한 것으로 보입니다.

흡연 중단 및 니코틴 탈중독 제품 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 431억 2,000만 달러에 이르고, CAGR은 10.7%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 개인 맞춤형 금연치료 도입 확대, 원격의료 기반 금연 프로그램 확대, 무연 대체품에 대한 수요 증가, 디지털 헬스 툴의 통합 발전, 담배 소비에 대한 규제 압력 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 니코틴 대체 요법 도입 증가, 디지털 금연 프로그램 이용 확대, 비니코틴 중독 치료 제품 수요 증가, 전자담배 대체품 확대, 행동 지원 솔루션에 대한 집중도 강화 등을 들 수 있습니다.

흡연 관련 질환 증가 추세는 향후 몇 년 동안 금연 보조 제품 및 니코틴 중독 치료 제품 시장 성장을 가속할 것으로 예측됩니다. 흡연 관련 질환이란 암, 호흡기 질환, 심혈관 질환 등 담배 사용의 유해한 영향에 의해 직접적으로 유발되는 건강 상태를 말합니다. 이러한 질병의 발생률 증가는 주로 전 세계 담배 소비량 증가와 유해한 담배 연기에 지속적으로 노출되어 발생합니다. 금연 및 니코틴 중독 치료 제품은 흡연자의 금연을 돕고 니코틴 의존도를 감소시켜 흡연 관련 질환의 발병 위험을 감소시키는 데 사용됩니다. 예를 들어, 2024년 5월 미국 비영리단체인 미국폐협회는 폐암 사망의 90%, 만성폐쇄성폐질환(COPD) 사망의 80%가 흡연에 기인한다고 보고했습니다. 현재 흡연자의 흡연 관련 질환의 73%가 만성폐질환이며, 전 흡연자의 50%가 이러한 질환을 경험한 것으로 나타나 흡연 관련 질환이 증가하고 있음을 알 수 있습니다. 따라서 이러한 질병의 유병률 증가는 금연 및 니코틴 중독 치료 제품 시장의 성장을 가속화할 것으로 예측됩니다.

금연 및 니코틴 중독 치료제 시장의 주요 기업들은 식물 유래 수용체 표적 치료제 개발에 집중하고 있습니다. 이 약물들은 뇌의 니코틴성 아세틸콜린 수용체와 상호 작용하여 니코틴에 대한 갈망과 보상 효과를 감소시킴으로써 통제된 금연을 돕습니다. 예를 들어, 2025년 9월 미국 소재 전문 제약사 Achieve Life Sciences는 니코틴 중독 치료제 'Cytisinicline'의 신약승인신청(NDA)을 FDA가 접수했다고 발표했습니다. 이 치료법은 표적화된 작용기전을 가지고 있으며, 흡연 및 전자담배 금연 프로그램과 함께 사용할 수 있으며, 3상 임상시험을 통해 명확한 치료 기간이 설정되어 있습니다. 이번 출시는 니코틴 의존증 치료에 있어 정밀 약물 치료의 보급 확대를 의미하며, 금연을 목표로 하는 수백만 명의 사람들에게 치료 옵션을 확대하는 계기가 될 것입니다. 다만, 규제 당국의 승인은 아직 보류 중이며, 실제 보급은 의사의 채용 상황과 환자의 복약 순응도에 따라 달라질 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Smoking cessation and nicotine de-addiction products are designed to help individuals quit smoking and reduce nicotine dependence, including nicotine replacement therapies, prescription medications, and behavioral support programs. These products assist in smoking cessation by reducing cravings, managing withdrawal symptoms, and supporting the behavioral changes necessary for quitting.

The main types of smoking cessation and nicotine de-addiction products include nicotine replacement therapy (NRT) products, drug therapy, nicotine sublingual tablets, nicotine inhalers, and e-cigarettes. Nicotine replacement therapy (NRT) products provide a controlled amount of nicotine to reduce withdrawal symptoms and help individuals quit smoking. These products come in various forms such as gum, inhalers, tablets, and others. They are distributed through several channels, including drug stores, hospital pharmacies, online pharmacies, and retail pharmacies.

Tariffs are influencing the smoking cessation and nicotine de-addiction products market by increasing costs of imported pharmaceutical ingredients, electronic components for inhalers and e-cigarettes, packaging materials, and medical-grade devices. North America and Europe are most affected due to reliance on cross-border pharmaceutical supply chains, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing product prices and impacting affordability for consumers. At the same time, they are encouraging domestic production, regional pharmaceutical manufacturing, and innovation in cost-efficient nicotine replacement and de-addiction solutions.

The smoking cessation and nicotine de-addiction products market research report is one of a series of new reports from The Business Research Company that provides smoking cessation and nicotine de-addiction products market statistics, including smoking cessation and nicotine de-addiction products industry global market size, regional shares, competitors with a smoking cessation and nicotine de-addiction products market share, detailed smoking cessation and nicotine de-addiction products market segments, market trends and opportunities, and any further data you may need to thrive in the smoking cessation and nicotine de-addiction products industry. This smoking cessation and nicotine de-addiction products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smoking cessation and nicotine de-addiction products market size has grown rapidly in recent years. It will grow from $25.91 billion in 2025 to $28.75 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to increasing awareness of smoking-related health risks, expansion of government anti-smoking campaigns, availability of over-the-counter cessation products, growth of prescription drug therapies, rising healthcare provider involvement.

The smoking cessation and nicotine de-addiction products market size is expected to see rapid growth in the next few years. It will grow to $43.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of personalized cessation therapies, expansion of telehealth-based cessation programs, rising demand for smoke-free alternatives, growing integration of digital health tools, increasing regulatory pressure on tobacco consumption. Major trends in the forecast period include increasing adoption of nicotine replacement therapies, rising use of digital smoking cessation programs, growing demand for non-nicotine de-addiction products, expansion of e-cigarette alternatives, enhanced focus on behavioral support solutions.

The increasing prevalence of smoking-related diseases is expected to drive the growth of the smoking cessation and nicotine de-addiction products market in the coming years. Smoking-related diseases are health conditions directly caused by the harmful effects of tobacco use, including cancers, respiratory diseases, and cardiovascular disorders. The rising incidence of these diseases is largely driven by increased global tobacco consumption and ongoing exposure to harmful tobacco smoke. Smoking cessation and nicotine de-addiction products are used to help individuals quit smoking and reduce nicotine dependence, thus lowering the risk of developing smoking-related diseases. For example, in May 2024, the American Lung Association, a US-based non-profit organization, reported that smoking was responsible for 90% of lung cancer deaths and 80% of chronic obstructive pulmonary disease (COPD) deaths. Among current smokers, 73% of smoking-related conditions are chronic lung diseases, while 50% of former smokers experience these conditions, indicating an increase in smoking-related diseases. Therefore, the rising prevalence of these diseases is expected to accelerate the growth of the smoking cessation and nicotine de-addiction products market.

Leading companies in the smoking cessation and nicotine de-addiction market are focusing on developing plant-derived receptor-targeted pharmacotherapies, which interact with nicotinic acetylcholine receptors in the brain to reduce cravings and the reward effects of nicotine, supporting controlled cessation. For instance, in September 2025, Achieve Life Sciences, a US-based specialty pharmaceutical company, announced that the FDA had accepted the New Drug Application (NDA) for Cytisinicline, a treatment for nicotine dependence. This therapy offers a targeted mechanism of action, is compatible with both smoking and e-cigarette cessation programs, and has a defined treatment duration based on Phase 3 clinical trials. This launch highlights the growing adoption of precision pharmacotherapy in nicotine de-addiction and expands treatment options for millions seeking to quit. However, regulatory approval is still pending, and the real-world adoption will depend on physician uptake and patient adherence.

In June 2024, Dr. Reddy's, an India-based global pharmaceutical company, acquired Haleon for an undisclosed amount. Dr. Reddy's acquisition of Haleon's nicotine addiction drug portfolio aims to strengthen its presence in the over-the-counter (OTC) drug market. Haleon is a UK-based provider of nicotine de-addiction products.

Major companies operating in the smoking cessation and nicotine de-addiction products market are Pfizer Inc., Philip Morris International Inc., Johnson & Johnson Inc., Merck & Co. Inc., AstraZeneca PLC, Imperial Brands plc, GlaxoSmithKline plc, British American Tobacco plc, Dr Reddy's Laboratories Ltd, Cipla Ltd, Cambrex Corp, Fertin Pharma, 22nd Century Group Inc., McNeil AB, Chrono Therapeutics Inc., Smoke Away LLC

North America was the largest region in the smoking cessation and nicotine de-addiction products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smoking cessation and nicotine de-addiction products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smoking cessation and nicotine de-addiction products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smoking cessation and nicotine de-addiction products market consists of sales of nicotine nasal spray, nicotine mouth spray, herbal smoking cessation products, nicotine lozenge tablets, and acupuncture kits for smoking cessation. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smoking Cessation And Nicotine De-Addiction Products Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses smoking cessation and nicotine de-addiction products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for smoking cessation and nicotine de-addiction products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smoking cessation and nicotine de-addiction products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Smoking Cessation And Nicotine De-Addiction Products Market Characteristics

3. Smoking Cessation And Nicotine De-Addiction Products Market Supply Chain Analysis

4. Global Smoking Cessation And Nicotine De-Addiction Products Market Trends And Strategies

5. Smoking Cessation And Nicotine De-Addiction Products Market Analysis Of End Use Industries

6. Smoking Cessation And Nicotine De-Addiction Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Smoking Cessation And Nicotine De-Addiction Products Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Smoking Cessation And Nicotine De-Addiction Products Total Addressable Market (TAM) Analysis for the Market

9. Smoking Cessation And Nicotine De-Addiction Products Market Segmentation

10. Smoking Cessation And Nicotine De-Addiction Products Market Regional And Country Analysis

11. Asia-Pacific Smoking Cessation And Nicotine De-Addiction Products Market

12. China Smoking Cessation And Nicotine De-Addiction Products Market

13. India Smoking Cessation And Nicotine De-Addiction Products Market

14. Japan Smoking Cessation And Nicotine De-Addiction Products Market

15. Australia Smoking Cessation And Nicotine De-Addiction Products Market

16. Indonesia Smoking Cessation And Nicotine De-Addiction Products Market

17. South Korea Smoking Cessation And Nicotine De-Addiction Products Market

18. Taiwan Smoking Cessation And Nicotine De-Addiction Products Market

19. South East Asia Smoking Cessation And Nicotine De-Addiction Products Market

20. Western Europe Smoking Cessation And Nicotine De-Addiction Products Market

21. UK Smoking Cessation And Nicotine De-Addiction Products Market

22. Germany Smoking Cessation And Nicotine De-Addiction Products Market

23. France Smoking Cessation And Nicotine De-Addiction Products Market

24. Italy Smoking Cessation And Nicotine De-Addiction Products Market

25. Spain Smoking Cessation And Nicotine De-Addiction Products Market

26. Eastern Europe Smoking Cessation And Nicotine De-Addiction Products Market

27. Russia Smoking Cessation And Nicotine De-Addiction Products Market

28. North America Smoking Cessation And Nicotine De-Addiction Products Market

29. USA Smoking Cessation And Nicotine De-Addiction Products Market

30. Canada Smoking Cessation And Nicotine De-Addiction Products Market

31. South America Smoking Cessation And Nicotine De-Addiction Products Market

32. Brazil Smoking Cessation And Nicotine De-Addiction Products Market

33. Middle East Smoking Cessation And Nicotine De-Addiction Products Market

34. Africa Smoking Cessation And Nicotine De-Addiction Products Market

35. Smoking Cessation And Nicotine De-Addiction Products Market Regulatory and Investment Landscape

36. Smoking Cessation And Nicotine De-Addiction Products Market Competitive Landscape And Company Profiles

37. Smoking Cessation And Nicotine De-Addiction Products Market Other Major And Innovative Companies

38. Global Smoking Cessation And Nicotine De-Addiction Products Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Smoking Cessation And Nicotine De-Addiction Products Market

40. Smoking Cessation And Nicotine De-Addiction Products Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기